Atossa Genetics Profit Margin 2012-2019 | ATOS
Current and historical gross margin, operating margin and net profit margin for Atossa Genetics (ATOS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Atossa Genetics net profit margin as of June 30, 2019 is 0%.
|Atossa Genetics Annual Profit Margins
|Atossa Genetics Quarterly Profit Margins
||Medical Instruments Manufacturing
Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA.